Comerica Bank’s KalVista Pharmaceuticals KALV Stock Holding History

Comerica Bank’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$8.38K	Hold	519	–	–	﹤0.01%	3283
2025 Q3	$6.32K	Sell	519 -192	-27%	-$2.65K	﹤0.01%	3361
2025 Q2	$8.04K	Hold	711	–	–	﹤0.01%	3264
2025 Q1	$8.21K	Buy	711 +192	+37%	+$1.96K	﹤0.01%	3221
2024 Q4	$4.4K	Sell	519 -133	-20%	-$1.38K	﹤0.01%	3338
2024 Q3	$7.55K	Hold	652	–	–	﹤0.01%	3238
2024 Q2	$7.68K	Buy	652 +133	+26%	+$1.55K	﹤0.01%	3218
2024 Q1	$6.16K	Hold	519	–	–	﹤0.01%	3293
2023 Q4	$6.36K	Sell	519 -27	-5%	-$246	﹤0.01%	3258
2023 Q3	$5.26K	Buy	+546	New	+$5.58K	﹤0.01%	3352

Other funds holding KALV

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Comerica Bank's KALV Position: Q4 2025 in Review

Comerica Bank held its KalVista Pharmaceuticals (KALV) position steady in Q4 2025 at 519 shares worth $8.38K. The position accounts for ﹤0.01% of the portfolio, ranked #3283.

Comerica Bank first reported a position in KALV in Q3 2023 and has held it in 10 quarters since. 161 funds tracked by Wall St. Rank hold KALV as of Q4 2025.

Comerica Bank held 519 shares of KalVista Pharmaceuticals worth $8.38K as of Q4 2025.
Comerica Bank left its KalVista Pharmaceuticals share count unchanged in Q4 2025.
KalVista Pharmaceuticals made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3283 holding.
Comerica Bank first reported a position in KalVista Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
161 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.